BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  McGinley Orthopedics Recruits Industry Leader as New CEO

  McGinley Orthopedics, a developer of innovative, patented drill technology that assists surgeons with a goal of changing the standard of care in medicine, has appointed Carl O’Connell as CEO, effective February 4th, 2019.

  February 13, 2019

   · 

  2 min read
• Business

  HIMSS ’19: Data-Driven Tools from Cigna and Express Scripts Boost Access to Real-Time Prescription Savings Opportunities

  Real-Time Prescription Benefit tool, now available for Cigna health care providers and customers, makes it easier to identify opportunities to decrease out of pocket costs.

  February 13, 2019

   · 

  6 min read
• Drug Development

  Innovent Announces First Patient Dosed in a Phase I Clinical Trial of an Anti-OX40 Antibody

  Innovent Biologics, Inc. announced that the first patient has been dosed in a Phase I clinical trial of IBI101, a recombinant fully human anti-tumor necrosis factor receptor superfamily member 4 monoclonal antibody.

  February 13, 2019

   · 

  4 min read
• Genetown

  GI Dynamics Announces Institutional Review Board Approval for EndoBarrier Pivotal Trial

  GI Dynamics® Inc., a medical device company that is developing EndoBarrier® for patients with type 2 diabetes and obesity, is pleased to announce that it has received Institutional Review Board approval to conduct its pivotal trial of EndoBarrier for type 2 diabetes and obesity.

  February 13, 2019

   · 

  4 min read
• Business

  CannTrust Adds to Leadership Team with Appointment of Greg Guyatt as CFO

  Ian Abramowitz to Lead Global Investments and Partnerships

  February 13, 2019

   · 

  5 min read
• Business

  DaVita Inc. 4th Quarter 2018 Results

  DaVita Inc. announced results for the quarter and year ended December 31, 2018.

  February 13, 2019

   · 

  42 min read
• BioMidwest

  UMN Medical School Study Provides New Insight Into the Use of Cell Replacement Therapies to Treat Muscular Dystrophies

  The University of Minnesota Medical School continues its legacy of advancing cell replacement therapies with a scientific breakthrough that highlights the promise of cell therapies for muscular dystrophy.

  February 13, 2019

   · 

  3 min read
• Business

  Invacare Corporation Announces Financial Results for the Fourth Quarter and Full Year Ended December 31, 2018

  Provides Update on Enhanced Transformation and Growth Plan, Introduces Full Year 2019 Guidance

  February 13, 2019

   · 

  33 min read
• Deals

  Revolutionary Dental Completes First Acquisition

  Revolutionary Dental Management, a start-up dental service organization, announced the completion of their first acquisition in the Middlesex County, New Jersey marketplace.

  February 13, 2019

   · 

  2 min read
• Policy

  Victory over Gilead! California Court Rules HIV Drug Personal Injury Cases May Proceed

  Superior Court of California, County of Los Angeles rejects all but one of Gilead’s arguments in demurrer seeking to have personal injury cases over its promotion of TDF-based HIV/AIDS medications that cause permanent damage to kidneys and bones dismissed.

  February 13, 2019

   · 

  3 min read